Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate
Article first published online: 30 DEC 2003
Copyright © 2002 American Association for the Study of Liver Diseases
Volume 35, Issue 3, pages 597–600, March 2002
How to Cite
Gilat, T., Leikin-Frenkel, A., Goldiner, I., Halpern, Z. and Konikoff, F. M. (2002), Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate. Hepatology, 35: 597–600. doi: 10.1053/jhep.2002.31868
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 21 DEC 2001
- Manuscript Received: 23 OCT 2001
- 1Epidemiology, risk factors, and pathogenesis of gallstones. In: AfdhalNH, ed. Gallbladder and Biliary Tract Diseases. New York: Marcel Dekker, Inc., 2000: 127–146..
- 3Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice. Lipids 2002 (in press)., , , , , .
- 14Current concepts of cholesterol gallstone formation and the prevention of biliary cholesterol crystallization, Book of abstracts, EASL 2001: 59–61., .
- 15Biliary and systemic effects of fatty acid bile acid conjugates (FABACs). Aliment Pharmacol Ther (submitted 2002)., , , , , , .
- 17Structure function relationships and lack of toxicity of fatty acid bile acid conjugates (FABACs). Gastroenterology 2001; 120(Suppl 1):A–13., , , , .